-
Sector Analysis
NewIndia General Insurance Market Size and Trends by Line of Business, Distribution, Competitive Landscape and Forecast to 2028
India General Insurance Market Report Overview The gross written premium of the Indian general insurance market was INR3 trillion ($36.5 billion) in 2023. The Indian general insurance sector growth peaked in 2022 and slowed down the following year majorly due to a decrease in liability, crop, credit guarantee, and marine, aviation, and transit (MAT) insurance premiums. The growth is anticipated to slow down over 2024–28 at a CAGR of more than 9%, due to elevated interest rates and medical inflation....
-
Consumer Insights
NewMass Affluent Banking in the ASEAN Region – Regional Breakdown by Market Trends, Investment Preferences and Competitor Benchmarking
This report analyzes the ASEAN region's mass affluent market. This includes overall mass affluent market size (number of individuals) and their distribution in the region. The report provides analysis of the factors driving affluence and examines mass affluent individuals’ financial goals, banking patterns, investment preferences, and insurance preferences. The report also covers the region's competitor benchmarking and case studies. The mass affluent and emerging affluent continue to grow in the ASEAN region, boosting spending at a retail level as well...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Lutetium Lu 177 Edotreotide in Neuroendocrine Gastroenteropancreatic Tumors (GEP-NET)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Lutetium Lu 177 Edotreotide in Neuroendocrine Gastroenteropancreatic Tumors (GEP-NET) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Lutetium Lu 177 Edotreotide in Neuroendocrine...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Tolvaptan in Polycystic Kidney Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tolvaptan in Polycystic Kidney Disease report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Tolvaptan in Polycystic Kidney Disease Drug Details: Tolvaptan (Samsca, Samtasu)...
-
Consumer Insights
Mass Affluent Banking in Greater China – Regional Breakdown by Market Trends, Investment Preferences and Competitor Benchmarking
Mass Affluent Banking Market in Greater China Report Overview Emerging affluents and mass affluents make up most of the affluent population in the Greater China region. The population of affluents has been exponential in the last decade in the region. However, the growth is expected to slow down in the upcoming years as the economies mature. Despite low growth, the number of mass affluent customers in the region is exceedingly large, offering a huge market to the financial providers looking...
-
Consumer Insights
China Retail Consumer Insights – Spending Intentions and Shopping Habits, 2024
This report provides detailed consumer insights into China's retail market. It centers on consumer sentiment, categories purchased, channel usage, motivations for purchasing, purchase frequency and the most popular global brands. Due to the crash in the real estate market and deflationary pressures, consumption has slowed down in the Chinese market. 52.3% of Chinese consumers intend to spend the same on retail goods in the next six months, while 26.2% intend to spend more as deflationary pressure subsides. Retailers need to...
-
Sector Analysis
NewUnited Kingdom (UK) Apparel Market Size and Trend Analysis by Category, Retail Channel, Consumer Attitudes, Brands and Forecast to 2028
UK Apparel Market Report Overview The UK apparel market size was valued at GBP60.7 billion in 2023. The market will witness slow growth at a CAGR of more than 1% during 2023-2028 as consumers will retain a cautious approach to spending, while resale channels and capsule wardrobes will also remain popular. The UK apparel market report offers data that showcase the trends in the market and sectors by value and volume. It also reveals the brand leaders by market share...
-
Product Insights
Likelihood of Approval Analysis for Retinitis Pigmentosa (Retinitis)
Overview How likely is it that the drugs in Retinitis Pigmentosa (Retinitis) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Retinitis Pigmentosa (Retinitis) Overview Retinitis pigmentosa refers to a group of...
-
Product Insights
Likelihood of Approval Analysis for Chronic Kidney Disease (Chronic Renal Failure)
Overview How likely is it that the drugs in Chronic Kidney Disease (Chronic Renal Failure) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Chronic Kidney Disease (Chronic Renal Failure) Overview Chronic...